EE292 Cost Effectiveness Analysis of Recombinant Zoster Vaccine Among 50 Years Old and Older in Sweden
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.558
https://www.valueinhealthjournal.com/article/S1098-3015(23)03688-4/fulltext
Title :
EE292 Cost Effectiveness Analysis of Recombinant Zoster Vaccine Among 50 Years Old and Older in Sweden
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03688-4&doi=10.1016/j.jval.2023.09.558
First page :
Section Title :
Open access? :
No
Section Order :
10049